Clinical Trial

NORCCAP: Norwegian Colorectal Cancer Prevention Trial

Study acronym: NORCCAP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to see if screening with flexible sigmoidoscopy (a flexible viewing tube) may reduce large bowel cancer and cancer deaths. The researchers also want to see if the addition of screening for occult blood in stools may contribute further to this aim. Additionally, the researchers also want to see to which extent (and in which direction) the study may influence overall endoscopic activity in the general population in the screening area and in areas where controlled screening is not established.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2005-07-06; most recent amendment 2026-04-08.
Trial Details
NCT Number NCT00119912
Lead Sponsor Norwegian Institute of Public Health
Collaborators: Norwegian Cancer Society
Conditions Colorectal Cancer, Adenoma
Enrollment 100,000 participants
Start Date 1999-01-01
Primary Completion 2036-12 (estimated)
Study Completion 2036-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-14